{"id":56340,"date":"2023-04-28T15:03:05","date_gmt":"2023-04-28T13:03:05","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/"},"modified":"2023-04-28T15:03:05","modified_gmt":"2023-04-28T13:03:05","slug":"2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/","title":{"rendered":"2seventy bio to Report First Quarter 2023 Financial Results on May 3, 2023"},"content":{"rendered":"
\n

CAMBRIDGE, Mass.–(BUSINESS WIRE)–2seventy bio, Inc.<\/a> (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, will announce its first quarter 2023 financial results on Wednesday, May 3, 2023. 2seventy bio will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a business update.<\/p>\n

<\/a><\/p>\n

\nParticipants can access the conference call live via webcast which will be available on the investor page of the company\u2019s website at https:\/\/ir.2seventybio.com\/<\/a>. Participants who wish to ask a question may register here at https:\/\/register.vevent.com\/register\/BI458c3098c2a64310b49e967327a906e7<\/a> to receive dial-in numbers and a unique pin to join the call. It is recommended that participants join 10 minutes prior to the event’s start. A replay of the call will be available on the 2seventy bio website following the completion of the call.<\/p>\n

\nAbout 2seventy bio<\/span><\/b><\/p>\n

\nOur name, 2seventy bio, reflects why we do what we do – TIME. Cancer rips time away, and our goal is to work at the maximum speed of translating human thought into action \u2013 270 miles per hour \u2013 to give the people we serve more time. We are building the leading immuno-oncology cell therapy company, focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape.<\/p>\n

\nWith a deep understanding of the human body\u2019s immune response to tumor cells and how to translate cell therapies into practice, we\u2019re applying this knowledge to deliver next generation cellular therapies that focus on a broad range of hematologic malignancies, including the first FDA-approved CAR T cell therapy for multiple myeloma, as well as solid tumors. Our research and development is focused on delivering therapies that are designed with the goal to \u201cthink\u201d smarter and faster than the disease. Importantly, we remain focused on accomplishing these goals by staying genuine and authentic to our \u201cwhy\u201d and keeping our people and culture top of mind every day.<\/p>\n

\nFor more information, visit www.2seventybio.com<\/a>.<\/p>\n

\nFollow 2seventy bio on social media: Twitter<\/a> and LinkedIn<\/a>.<\/p>\n

\n2seventy bio is a trademark of 2seventy bio, Inc.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia & Investors<\/b>:
\n
Jenn Snyder
\n
617-448-0281
\n
Jenn.snyder@2seventybio.com<\/a><\/p>\n

Morgan Adams
\n
774-313-9852
\n
Morgan.adams@2seventybio.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CAMBRIDGE, Mass.–(BUSINESS WIRE)–2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, will announce its first quarter 2023 financial results on Wednesday, May 3, 2023. 2seventy bio will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a business update. Participants can access the conference call live … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56340","6":"format-standard","7":"category-industry"},"yoast_head":"\n2seventy bio to Report First Quarter 2023 Financial Results on May 3, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2seventy bio to Report First Quarter 2023 Financial Results on May 3, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass.–(BUSINESS WIRE)–2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, will announce its first quarter 2023 financial results on Wednesday, May 3, 2023. 2seventy bio will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a business update. Participants can access the conference call live ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-28T13:03:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230428005266\/en\/1257457\/21\/2seventy_logo_for_BW.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"2seventy bio to Report First Quarter 2023 Financial Results on May 3, 2023\",\"datePublished\":\"2023-04-28T13:03:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\\\/\"},\"wordCount\":377,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230428005266\\\/en\\\/1257457\\\/21\\\/2seventy_logo_for_BW.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\\\/\",\"name\":\"2seventy bio to Report First Quarter 2023 Financial Results on May 3, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230428005266\\\/en\\\/1257457\\\/21\\\/2seventy_logo_for_BW.jpg\",\"datePublished\":\"2023-04-28T13:03:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230428005266\\\/en\\\/1257457\\\/21\\\/2seventy_logo_for_BW.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230428005266\\\/en\\\/1257457\\\/21\\\/2seventy_logo_for_BW.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2seventy bio to Report First Quarter 2023 Financial Results on May 3, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2seventy bio to Report First Quarter 2023 Financial Results on May 3, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/","og_locale":"en_US","og_type":"article","og_title":"2seventy bio to Report First Quarter 2023 Financial Results on May 3, 2023 - Pharma Trend","og_description":"CAMBRIDGE, Mass.–(BUSINESS WIRE)–2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, will announce its first quarter 2023 financial results on Wednesday, May 3, 2023. 2seventy bio will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a business update. Participants can access the conference call live ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-28T13:03:05+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230428005266\/en\/1257457\/21\/2seventy_logo_for_BW.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"2seventy bio to Report First Quarter 2023 Financial Results on May 3, 2023","datePublished":"2023-04-28T13:03:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/"},"wordCount":377,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230428005266\/en\/1257457\/21\/2seventy_logo_for_BW.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/","url":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/","name":"2seventy bio to Report First Quarter 2023 Financial Results on May 3, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230428005266\/en\/1257457\/21\/2seventy_logo_for_BW.jpg","datePublished":"2023-04-28T13:03:05+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230428005266\/en\/1257457\/21\/2seventy_logo_for_BW.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230428005266\/en\/1257457\/21\/2seventy_logo_for_BW.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/2seventy-bio-to-report-first-quarter-2023-financial-results-on-may-3-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"2seventy bio to Report First Quarter 2023 Financial Results on May 3, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56340","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56340"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56340\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56340"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56340"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56340"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}